EncepHeal Therapeutics, Inc.

EncepHeal Therapeutics, Inc. At EncepHeal Therapeutics, our mission is to enhance the development of first-in-class medicines to improve treatment of mental health disorders.

Our vision is to propel innovations from the lab into safe, affordable, and effective medicines for our patients. We are bringing together top researchers and practitioners in the fields of psychiatry, neurology, neuropathology, and neuropharmacology for the efficient development of first-in-class medicines to prevent, treat, and cure neurological diseases. Through working partnerships with academ

Our vision is to propel innovations from the lab into safe, affordable, and effective medicines for our patients. We are bringing together top researchers and practitioners in the fields of psychiatry, neurology, neuropathology, and neuropharmacology for the efficient development of first-in-class medicines to prevent, treat, and cure neurological diseases. Through working partnerships with academ

Y Combinator
07/28/2020

Y Combinator

Congrats to the EncepHeal Therapeutics, Inc. (YC S19) team on being awarded a Blueprint Neurotherapeutics Network (BPN) grant from the National Institutes of Health (NIH) to develop novel medications for co***ne addiction: http://ow.ly/HRSk50AKsPB

Today we announced our new funding and collaboration with the NIH Blueprint Neurotherapeutics Network. We are really exc...
07/28/2020
EncepHeal Therapeutics Announces Award from the National Institutes of Health Blueprint Neurotherapeutics Network to Advance Innovative Medications to Treat Co***ne Addiction | EncepHeal

Today we announced our new funding and collaboration with the NIH Blueprint Neurotherapeutics Network. We are really excited to continue our work on developing medications to treat substance abuse.

EncepHeal Therapeutics Announces Award from the National Institutes of Health Blueprint Neurotherapeutics Network to Advance Innovative Medications to Treat Co***ne Addiction WINSTON SALEM – EncepHeal Therapeutics, Inc. today announced it has been awarded a Blueprint Neurotherapeutics Network (BPN...

Our CEO Aaron Lazarus had the chance to give the concluding talk at the NC Biotech 35 Anniversary celebration early this...
11/19/2019
Building a life science hub: NC Biotech Center celebrates 35 years of visionary leadership | WRAL TechWire

Our CEO Aaron Lazarus had the chance to give the concluding talk at the NC Biotech 35 Anniversary celebration early this month. Thank you to the NC Biotech Center for the continued support and the opportunity to celebrate the Center's achievements.

The North Carolina Biotech Center celebrated 35 years of visionary leadership that helped propel the state to the top tier of biotech hubs in the U.S. and globally.

EncepHeal Therapeutics, Inc.
10/04/2019

EncepHeal Therapeutics, Inc.

A new study shows how s*x differences and more specifically how the menstrual cycle can influence co***ne addiction.
03/15/2019
Estrous Cycle Phase Influences Co***ne Craving in Rats

A new study shows how s*x differences and more specifically how the menstrual cycle can influence co***ne addiction.

Menstrual cycle may influence addiction risk in women, according to a new study. In female rats, craving for co***ne during abstinence from the drug was stronger during estrus—the phase in which ovulation occurs—than non-estrus, and female rats were more prone to relapse of co***ne use than male...

The National Institute on Drug Abuse (NIDA) gives some basic facts and statistics on co***ne use and addiction.
03/08/2019
What is co***ne?

The National Institute on Drug Abuse (NIDA) gives some basic facts and statistics on co***ne use and addiction.

Photo by ©iStock.com/Rafal Cichawa

An interesting article highlighting the development of a potential compound to treat methamphetamine addiction.
07/31/2018

An interesting article highlighting the development of a potential compound to treat methamphetamine addiction.

Read about the quest to develop a first-ever medication to treat methamphetamine addiction.
http://bit.ly/2InLd0r #NIDAnotes #NIDAscience

A great post by former EncepHeal colleague Elena Vidrascu discussing the impact of screen time on behavior.
06/29/2018
Screen Time and Content Might Increase Youth’s Risk to Future Substance Abuse, Part I

A great post by former EncepHeal colleague Elena Vidrascu discussing the impact of screen time on behavior.

Elena Vidrascu, MSc, discusses whether and how screen time and media content may be impacting the developing minds of youngsters growing up in the digital age. She examines the potential consequences and correlations of screen time, attention, and substance abuse.

Prescription stimulants such as Adderall are abused regularly by young adults. Awareness of the signs of withdrawal from...
06/26/2018

Prescription stimulants such as Adderall are abused regularly by young adults. Awareness of the signs of withdrawal from these drugs can be important in identifying a problem and seeking treatment.

Symptoms from prescription stimulant withdrawal may include fatigue, depression and sleep problems.
https://www.drugabuse.gov/publications/drugfacts/prescription-stimulants #DrugFacts #FridayFacts

EncepHeal has been announced as a presenting company for the BIO Start-Up Stadium in Boston, MA from June 4-7.
06/01/2018
Start-Up Stadium | 2018 BIO International Convention

EncepHeal has been announced as a presenting company for the BIO Start-Up Stadium in Boston, MA from June 4-7.

'); mywindow.document.close(); // necessary for IE >= 10 mywindow.focus(); // necessary for IE >= 10*/ mywindow.print(); mywindow.close(); return true; } $(document).ready(function () { $('.btn-print').hide(); if (window.location.href.toLowerCase().indexOf("/schedule/") > -1) { $('.btn-print').css('...

04/25/2018

EncepHeal is participating in the inaugural Innovation 2 Impact course at Yale university. Follow along with us on Twitter at @innovateatyale

An insightful interview conducted by a former EncepHeal colleague Elena Vidrascu discussing the aspects of long-term tre...
04/03/2018
Audio Interview: Mike Connors on Treating Youth & Young Adults Struggling with Substance Abuse & Addiction - JPHMP Direct

An insightful interview conducted by a former EncepHeal colleague Elena Vidrascu discussing the aspects of long-term treatment of addiction with Mike Connors, the Director of the Insight Program in Greensboro, NC. They provide substance use treatment for youth and young adults.

by Elena Vidrascu, MSc JPHMP presents Preventing America’s Next Drug Epidemic: A Multidisciplinary Approach, a new series designed to introduce the many facets of substance abuse, and how integrating the work of multiple partners may be the best approach towards prevention and treatment. This seri...

Here is our CEO Aaron Lazarus presenting during the lightning round at the CED Life Science conference this week. He als...
03/02/2018

Here is our CEO Aaron Lazarus presenting during the lightning round at the CED Life Science conference this week. He also gave an amazing presentation for the pre-conference university showcase as a Wake Forest showcase company. Great job Aaron! Thank you CED for the opportunity to share EncepHeal's story.

EncepHeal is developing an NIH invention with NIH grant funding. We recognize that the involvement of the NIH and NIDA i...
02/23/2018
$100B in NIH-funded research played an important role in all 210 new drugs approved over 7 years — study

EncepHeal is developing an NIH invention with NIH grant funding. We recognize that the involvement of the NIH and NIDA in progressing these compounds forward has been and will continue to be pivotal in achieving a future FDA approval for a co***ne addiction pharmacotherapy.

The next time someone challenges the importance of NIH-funded research in drug development, you might want to point them to a new study that highlights the foundational role the Institutes plays in biopharma research. The study — published in the Proceedings of the National Academy of Sciences —...

EncepHeal will be presenting at the CED Life Science Conference at the end of this month. The company will be presenting...
02/13/2018
CED Life Science Conference | Overview & Registration

EncepHeal will be presenting at the CED Life Science Conference at the end of this month. The company will be presenting during the lightning round and the Pre-conference session: University Life Science Startups

https://cednc.org/LSC

Looking for an event showcasing entrepreneurs? Come network with investors, biotech innovators and more at the CED Life Science Conference in Raleigh, NC.

A great article written by the Wake Forest Innovation Quarter on EncepHeal.
02/07/2018
Wake Forest Innovation Quarter

A great article written by the Wake Forest Innovation Quarter on EncepHeal.

Meet the youthful founders of EncepHeal Therapeutics, Inc., a biotech start-up born in the Innovation Quarter, and learn how the graduate students-turned-entrepreneurs ended up on the cutting-edge of treating drug addiction.

NIDA is a great source of information regarding addiction for the general public as well as physicians in training.
11/22/2017

NIDA is a great source of information regarding addiction for the general public as well as physicians in training.

Clinician Educators–DYK these #NIDAMED substance use disorder/addiction curriculum resources are currently used by top medical schools? Created by leading educators in the field. Check them out---
https://www.drugabuse.gov/nidamed/centers-excellence/curriculum-resources-overview

10/24/2017
Presenting Companies | SEBIO 2017

We are happy to announce that EncepHeal Therapeutics will be presenting at the 2017 SEBIO Investor and Partnering Forum in Pinehurst, NC.

https://www.southeastbio.org/presenting-companies/

Bantam Pharmaceutical is a privately held biopharmaceutical company using a precision medicine approach for the discovery and development of novel small molecule cancer therapeutics. Clinical focus is on therapeutics for KRAS mutated solid tumors and diffuse large B-cell lymphomas.

Similar results demonstrating the effectiveness of deep brain stimulation have also been shown in studies of co***ne add...
10/17/2017
The National Institute on Drug Abuse - NIDA

Similar results demonstrating the effectiveness of deep brain stimulation have also been shown in studies of co***ne addiction. New and innovative treatments like these are needed to address this complex disease.

NIH-funded animal study suggests that electrical stimulation of neurons deep in the brain could reduce relapse to he**in:

https://www.drugabuse.gov/news-events/nida-notes/2017/10/deep-brain-stimulation-attenuates-rats-responses-to-he**in?utm_source=Facebook&utm_medium=National&utm_content=Oct2017&utm_campaign=NIDANotes

10/05/2017
NC Biotech Announcement

EncepHeal Therapeutics Receives $150,000 Notice of Award from the North Carolina Biotechnology Center
http://www.encepheal.com/nc-biotech-announcement.html

EncepHeal Therapeutics has been awarded a $150,000 Small Business Research Loan from the North Carolina Biotechnology Center. These funds will supplement the work underway in a Phase I SBIR grant from the National Institute on Drug Abuse (NIDA) granted earlier this year, which is intended to develop...

ExitEvent
09/13/2017
ExitEvent

ExitEvent

Keep an eye on these startups!

Address

486 N Patterson Ave., Suite 204​
Winston-Salem, NC
27101

General information

Our goal is to establish a hub of innovation to accelerate the research and development of novel therapeutics to prevent, treat, and cure neuropsychological disorders. We offer our partner organizations and pharmaceutical partners access to our experimental drugs and the opportunity to access preclinical drug candidates. The company’s initial products are Psychostimulant Addiction Therapeutics (PATs) developed by the National Institutes of Health (NIH). Our initial focus is to guide safe and effective PATs through clinical trials and into the hands of people who need them.

Alerts

Be the first to know and let us send you an email when EncepHeal Therapeutics, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to EncepHeal Therapeutics, Inc.:


Other Winston-Salem engineering companies

Show All